Addiction Science & Clinical Practice: a new partnership with the Grayken Center for Addiction at Boston Medical Center to usher in our next phase

2024-9-13

Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study

2024-9-12

Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital

2024-9-11

Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial

2024-9-11

Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals

2024-9-9

Integrated telehealth intervention to reduce chronic pain and unhealthy drinking among people living with HIV: protocol for a randomized controlled trial

2024-9-5

Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol

2024-9-3

Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study

2024-9-2

Prevalence of alcohol use disorders documented in electronic health records in primary care across intersections of race or ethnicity, sex, and socioeconomic status

2024-8-30

Ketamine-assisted buprenorphine initiation: a pilot case series

2024-8-29

Introduction to the special series: using evidence to enhance health services for individuals using drugs in rural communities

2024-8-23

“Moving beyond silos”: focus groups to understand the impact of an adapted project ECHO model for a multidisciplinary statewide forum of substance use disorder care leaders manuscript authors

2024-8-8

Exploring perceptions of genetic risk and the transmission of substance use disorders

2024-8-2

Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder

2024-7-27

Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial

2024-7-23

A case of severe opioid and methamphetamine use disorder in a 14 year old

2024-7-19

Patient experiences of buprenorphine dispensing from a mobile medical unit

2024-7-18

Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial

2024-7-10

Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders

2024-6-25

Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder

2024-6-18

The identification and treatment of alcohol problems in primary care (iTAPP) study: protocol for a stepped wedge cluster randomized control trial testing the 15-method in a primary care setting

2024-6-13

Using 42 CFR part 2 revisions to integrate substance use disorder treatment information into electronic health records at a safety net health system

2024-6-7

PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs

2024-6-3

Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods

2024-5-30

Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities

2024-5-27

Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges

2024-5-23

Confidence in providing methadone maintenance treatment of primary care providers in Vietnam

2024-5-22

A social network analysis approach to assess COVID19-related disruption to substance use treatment and informal social interactions among people who use drugs in Scotland

2024-5-22

Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden

2024-5-19

Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol

2024-5-16

Retention of people who inject drugs enrolled in a ‘medications for opioid use disorder’ (MOUD) programme in Uganda

2024-5-15

Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway

2024-5-14

Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda

2024-5-14

Boosting self-efficacy and improving practices for smoking prevention and cessation among South American cancer care providers with a web-based algorithm

2024-5-7

Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for individuals with alcohol use disorder

2024-5-6

An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report

2024-5-1

Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial

2024-4-28

Training health professionals to reduce overreporting of birthing people who use drugs to child welfare

2024-4-26

Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder

2024-4-26

Internet-delivered therapy for alcohol misuse: engagement, satisfaction, and outcomes when patients select their preference for therapist- or self-guided treatment

2024-4-20

Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder

2024-4-11

The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial

2024-4-9

Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process

2024-4-8

Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies

2024-4-8

Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study

2024-4-5

Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use

2024-4-3

Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study

2024-4-2

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

2024-3-26

Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services

2024-3-25

Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment

2024-3-21